Rocket Pharmaceuticals, Inc.
RCKT
$7.88
$0.192.47%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.54% | -0.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.69% | -5.82% | |||
| Operating Income | 9.69% | 5.82% | |||
| Income Before Tax | 9.58% | 4.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.58% | 4.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.58% | 4.20% | |||
| EBIT | 9.69% | 5.82% | |||
| EBITDA | 10.00% | 6.04% | |||
| EPS Basic | 12.72% | 4.62% | |||
| Normalized Basic EPS | 13.34% | 5.05% | |||
| EPS Diluted | 12.72% | 4.62% | |||
| Normalized Diluted EPS | 13.34% | 5.05% | |||
| Average Basic Shares Outstanding | 3.58% | 0.44% | |||
| Average Diluted Shares Outstanding | 3.58% | 0.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
